##plugins.themes.bootstrap3.article.main##

Placenta previa is a placenta that has implanted in the lower uterine segment, thus covering all or part of the internal uterine ostium. The prevalence of placenta previa in developed countries ranges from 0.26 to 2.00% of all pregnancies, while in Indonesia it has been reported by several researchers to range from 2.4 to 3.56% of all pregnancies. Sectio cesarean is a risk factor for placenta previa and the risk of causing placenta accreta which can increase cases of bleeding and hysterectomy. However, placenta accreta can only be established after delivery. So that early detection of placenta accreta can be used to determine the condition of the placenta during pregnancy. In cesarean section, an incision is made in the uterine wall so that it can result in atrophic changes in the decidua and reduced vascularity resulting in the placenta moving to a place with higher vascularity or sticking deeper at the implantation site. The Placenta Acreta Index is a value for each sonographic parameter that is used to assess the probability of the extent to which the placenta invades the uterine wall. The probability value of placental invasion is included with the total score. Where the total value is 0.1,2 and so on up to above 8 in a row with an invasion probability value of 5%, 10%, 19%, 33%, 51%, 69%, 83%, 91% and 96%. Placenta accreta in former cesarean section can be confirmed by the placenta accreta index score.

Downloads

Download data is not yet available.

References

  1. Tjokroprawiro BA. Caesarean hysterectomy in a patient with placenta accreta spectrum disorders. BMJ Case Rep. 2021; 14(3): e242044.
    DOI  |   Google Scholar
  2. Djusad S, Dilmy MAF, Suastika AV, Fadhly RMA, Purwosunu Y. Ureter injury in obstetric hysterectomy with placenta accreta spectrum: Case report. Int J Surg Case Rep. 2021; 88: 106489.
    DOI  |   Google Scholar
  3. Li X, Feng Y. Complete placenta previa in the second trimester: clinical and sonographic factors associated with its resolution. Ginekol Pol. 2019; 90(9): 539-543.
    DOI  |   Google Scholar
  4. Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018; 218(1): 75-87.
    DOI  |   Google Scholar
  5. Liu X, Wang Y, Wu Y, Zeng J, Yuan X, Tong C, et al. What We Know About Placenta Accreta Spectrum (PAS). European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021; 259: 81-89
    DOI  |   Google Scholar
  6. Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine, Cahill AG, et al. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018; 219(6): B2-B16.
    DOI  |   Google Scholar
  7. Berkley EM, Abuhamad AZ. Prenatal diagnosis of placenta accreta; Is sonography all we need? J Ultrasound Med. 2013; 32: 1345-50.
    DOI  |   Google Scholar
  8. Sivasankar C. Perioperative management of undiagnosed placenta percreta:case report and management strategies. Int J Womens Health. 2012; 4: 451-54
    DOI  |   Google Scholar
  9. Donovan BM, Shainker SA. Placenta Accreta Spectrum. Neoreviews. 2021; 22(11): e722-e733.
    DOI  |   Google Scholar
  10. Abdulsalam RAH, Mohammed EDA, Amr MEH, Marwa L. Histological and Histopathological Study of Lower Uterine Segement After Previous Cesarean Section and Placenta Accreta. International Jounal of Basic and Applied Science. 2017; 6(4): 90-101.
    DOI  |   Google Scholar
  11. Jauniaux E, Chantraine F, Silver RM, Langhoff-Ross J, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet. 2018; 140(3): 256-73.
    DOI  |   Google Scholar
  12. Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017; 217(1): 27-36.
    DOI  |   Google Scholar
  13. Bartels HC, Postle JD, Downey P, Brennan DJ. Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers. Dis Markers. 2018; 2018: 1507674.
    DOI  |   Google Scholar
  14. Committee on Obstetric Practice. Committee opinion no. 529: placenta accreta. Obstet Gynecol. 2012; 120(1): 207-11
    DOI  |   Google Scholar
  15. Jauniaux E, Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta. 2012; 33(4): 244-51
    DOI  |   Google Scholar
  16. Binici O, Buyukfirat E. Anesthesia for Cesarean Section in Parturients with Abnormal Placentation: A Retrospective Study. Cureus. 2019; 11(6).
    DOI  |   Google Scholar
  17. Orbach-Zinger S, Weiniger CF, Aviram A, Balla A, Fein S, Eidelman LA, et al. Anesthesia management of complete versus incomplete placenta previa: retrospective cohort study. J Matern Fetal Neonatal Med. 2018; 31(9): 117-176.
    DOI  |   Google Scholar
  18. Nelson T, Change E, Goordier C, Mateus-Nino J. Validation of The Placenta Accreta Index (PAI): Improving the antenatal diagnosis of the morbidly adherent placenta. American Journal of Obstetrics & Gynecology. 2017: S133-134.
    DOI  |   Google Scholar
  19. Cali G, Forlani F, Lees C, Timor-Tritsch I, Palacios-Jaraquemada J, Dall’asta A, et al. Prenatala ultrasound staging system for placenta accrete spectrum disorders. Ultrasound Obstet Gynecol. 2019; 53: 752-760.
    DOI  |   Google Scholar


Most read articles by the same author(s)

1 2 > >>